Bayer submits contraceptive Qlaira for FDA approval

07/8/2009 | Reuters

Bayer submitted its birth-control pill Qlaira for FDA review. The drug, which is also indicated for excessive menstrual bleeding, contains a combination of the body-identical oestrogen called estradiol and the progestin dienogest.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Fort Worth, TX
Director, Senior Legal Counsel
Fort Worth, TX